EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Postnatal corticosteroids and developmental outcomes in extremely preterm or extremely low birth weight infants: The Victorian Infant Collaborative Study 2016–17 cohort

Ellen Douglas, Kate A Hodgson iD, Joy E Olsen iD, Brett J Manley iD, Calum T Roberts iD, Elisha Josev, Peter J Anderson, Lex W Doyle, Peter G Davis, Jeanie L Y Cheong, Victorian Infant Collaborative Study Group

Acta Paediatrica · 2023

DOI: 10.1111/apa.16696 ↗

Kurz gefasst

Kommentar in der Zeitschrift Acta Paediatrica, 2023. Verfasst von Ellen Douglas und 10 weiteren Autor:innen. Beteiligte Einrichtung: Newborn Research Centre, Royal Women's Hospital, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Cerebral Palsy, Bronchopulmonary Dysplasia. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council of Australia, Emerging Leadership Fellowship, the Medical Research Future Fund of Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Systemic postnatal corticosteroids are used to treat or prevent bronchopulmonary dysplasia (BPD) in extremely preterm (EP) or extremely low birth weight (ELBW) infants but are associated with long‐term harm. We aimed to assess the relationship between cumulative postnatal corticosteroid dose and neurodevelopmental outcomes.

Methods

Longitudinal cohort study of all EP/ELBW livebirths in Victoria, Australia 2016–2017. Perinatal data were collected prospectively. Neurodevelopmental assessment was performed at 2 years' corrected age. Linear and logistic regression were used to determine relationships between cumulative corticosteroid dose and neurodevelopment, adjusted for gestational age, birth weight, sex and major intraventricular haemorrhage.

Results

Seventy‐six EP/ELBW infants received postnatal corticosteroids to treat or prevent BPD, 62/65 survivors were seen at 2 years. Median (IQR) cumulative postnatal corticosteroid dose was 1.36 (0.92–3.45) mg/kg dexamethasone equivalent. Higher cumulative corticosteroid dose was associated with increased odds of cerebral palsy, adjusted OR (95% CI) 1.47 (1.04, 2.07). Higher cumulative corticosteroid dose was also associated with lower cognitive and motor developmental scores, however, this weakened after adjustment for confounding variables: cognitive composite score adjusted coefficient (95% CI) −1.3 (−2.7, 0.1) and motor composite score adjusted coefficient (95% CI) −1.3 (−2.8, 0.2).

Conclusion

Higher cumulative postnatal corticosteroid dose in EP/ELBW infants is associated with increased odds of cerebral palsy at 2 years' corrected age. Adequately powered studies are needed to assess the independent effects of cumulative steroid dose on neurodevelopmental outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral PalsyBronchopulmonary DysplasiaInfant, NewbornInfantHumansInfant, Extremely Low Birth WeightDexamethasoneInfant, Extremely PrematureLongitudinal StudiesAdrenal Cortex HormonesVictoria

Stichwörter der Autor:innen

developmentprematuritysteroid

Substanzen

DexamethasoneAdrenal Cortex Hormones

Autor:innen und Institutionen

  • Newborn Research Centre, Royal Women's Hospital, Melbourne, Victoria, Australia.
  • Department of Obstetrics and Gynaecology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
  • Monash Newborn, Monash Children' Hospital, Melbourne, Victoria, Australia.
  • Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Victoria, Australia.
  • Mercy Hospital for Women, Melbourne, Victoria, Australia.

ORCID-Profile: Kate A Hodgson, Joy E Olsen, Brett J Manley, Calum T Roberts

Förderung

  • National Health and Medical Research Council of Australia
  • Emerging Leadership Fellowship
  • the Medical Research Future Fund of Australia
  • Victorian Government's Operational Infrastructure Support Program

Zitieren

APA

Douglas, E., Hodgson, K. A., Olsen, J. E., Manley, B. J., Roberts, C. T., Josev, E., Anderson, P. J., Doyle, L. W., Davis, P. G., Cheong, J. L. Y., & Victorian Infant Collaborative Study Group (2023). Postnatal corticosteroids and developmental outcomes in extremely preterm or extremely low birth weight infants: The Victorian Infant Collaborative Study 2016–17 cohort. Acta Paediatrica. https://doi.org/10.1111/apa.16696

Vancouver

Douglas E, Hodgson KA, Olsen JE, Manley BJ, Roberts CT, Josev E, et al. Postnatal corticosteroids and developmental outcomes in extremely preterm or extremely low birth weight infants: The Victorian Infant Collaborative Study 2016–17 cohort. Acta Paediatrica. 2023. doi:10.1111/apa.16696

BibTeX
@article{Douglas2023,
  author = {Douglas, Ellen and Hodgson, Kate A and Olsen, Joy E and Manley, Brett J and Roberts, Calum T and Josev, Elisha and Anderson, Peter J and Doyle, Lex W and Davis, Peter G and Cheong, Jeanie L Y and Victorian Infant Collaborative Study Group, Victorian Infant Collaborative Study Group},
  title = {Postnatal corticosteroids and developmental outcomes in extremely preterm or extremely low birth weight infants: The Victorian Infant Collaborative Study 2016–17 cohort},
  journal = {Acta Paediatrica},
  year = {2023},
  doi = {10.1111/apa.16696}
}
Kostenlos starten →